Absci Corporation Stock News

Absci Corp (NASDAQ: ABSI ) is trading Full story available on Benzinga.com

Find out about the company enjoying a more than 50% rise for its stock.

David Rosenberg, chief economist and strategist at Rosenberg Research and the former chief North American economist at Merrill Lynch, isn't buying the tough talk from the Fed

Shares of Absci Corp. skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to $610 million in upfront fees and milestone payments from Merck & Co. Inc. as part of a research collaboration agreement. Trading volume ballooned to 9.7 million shares, compared with the full-day average of about 324,800 shares, to make the stock the biggest gainer and most actively traded ahead of the open. Under the collaboration, Absci''s Bionic Protein amino acid technology will be used to produce enzymes tailored to Merck''s biomanufacturing platform. Merck also has the option to nominate up to three targets and enter into a drug discovery collaboration agreement. The stock, which closed at a record low of $6.14 on Thursday, had tumbled 42.9% over the past three months through Thursday, while the iShares Biotechnology ETF has shed 8.8% and the S&P 500 has gained 6.7%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

Absci Corp (ABSI) shares closed today 12.8% lower than it did at the end of yesterday. The stock is currently down 25.1% year-to-date, down 71.6% over the past 12 months, and down 71.6% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $8.72 and as low as $6.12 this week.Shares closed 80.5% below its 52-week high and 0.3% above its 52-week low.Trading volume this week was 27.2% higher than the 10-day average and 26.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -2432.9% The company's stock price performance over the past 12 months lags the peer average by 913.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Absci Corp (ABSI) shares closed today at 0.3% above its 52 week low of $6.12, giving the company a market cap of $568M. The stock is currently down 25.1% year-to-date, down 71.6% over the past 12 months, and down 71.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 26.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -2432.9% The company's stock price performance over the past 12 months lags the peer average by 913.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Futures Rise Ahead Of Jobs Data That Could "Wreak Havoc In Markets" US index futures climbed on Friday, paring this weeks losses fractionally as investors braced for jobs data that should provide clues about the pace of Fed tightening and which is expected to come in strong (whisper number at 502k, above 447k estimate, up from 210K last month; Wednesdays ADP print was 807k, well above 410k estimate, our full preview is here ) but not too strong - remember we now live in a "good news is bad news" world - or else the market will freak out that the Fed will hike even faster than is currently expected. Nasdaq futures also showed signs of recovery after a three-day selloff even as cryptocurrencies crashed again during the Asian session. As of 730am, emini S&P futures were up 4 points or 0.1%, Nasdaq futures were 0.24% higher, or 37 points and Dow futures were unchanged.Treasuries were steady, with the two-year yield heading for the biggest weekly spike since October 2019. Crude oil headed for the longest streak of weekly gains since October on tightening supplies.

Dogness (DOGZ) stock is on a run Friday as investors react to recent volatility surrounding the shares alongside heavy trading. The post DOGZ Alert: Why Pet Penny Stock Dogness Is Running Higher Today

Absci (ABSI) stock is flying higher on Friday after announcing a major research collaboration agreement with Merck (MRK). The post ABSI Stock: 7 Things for Investors to Know About the Merck Deal That

Absci (ABSI) soars 43.5% premarket after entering into a research collaboration with Merck (MRK)

Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Protein™ technologies Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Prot

Absci Corp (NASDAQ: ABSI) is trading higher Friday after the company announced a research collaboration with Merck & Co Inc (NYSE: MRK). The collaboration will utilize Absci's AI-powered Integrated

Shares of Absci Corp. ABSI, -12.78% skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to $610 million in upfront fe

The stock price of Absci Corp (NASDAQ: ABSI) increased by over 30% pre-market today. This is why it happened.